Literature DB >> 33722204

Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan.

Yong Chong1, Naoki Tani2, Hideyuki Ikematsu3, Nobuto Terazawa4, Hitoshi Nakashima4, Nobuyuki Shimono2,5, Koichi Akashi2, Yosuke Tanaka4.   

Abstract

BACKGROUND: The Pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has critically impacted the spread of infection within nursing facilities. We evaluated the usefulness of genetic and serological tests conducted during a COVID-19 outbreak in a nursing facility in Japan.
METHODS: After the first identification of SARS-CoV-2 infection, a comprehensive, facility- and/or unit-wide PCR testing from nasopharyngeal swabs was repeatedly performed in a three-unit facility including 99 residents with dementia and 53 healthcare personnel. Additionally, PCR testing was conducted separately for residents and staff with fever of ≥37.5 °C. Facility-wide serological testing, including rapid kit testing and quantitative assay, was conducted twice over 1 month apart.
RESULTS: A total of 322 PCR and 257 antibody tests were performed. 37 (24.3%) of the 152 individuals (25/99 residents, 25.3%; 12/53 staff, 22.6%) were identified as PCR-positive. Seven residents died with a mortality of 7.1% (7/99). Among the 37 individuals, 10 (27.0%) were asymptomatic at the time of testing. PCR positivity was concentrated on one unit (Unit 1) (20/30 residents, 66.7%; 9/14 staff, 64.3%). The other units showed a limited spread of infection. In unit-wide and separate tests, PCR positivity detection was highly prevalent (22.9 and 44.4%, respectively) in Unit 1, compared with that in the other units. Serological testing identified two additional infected residents with a negative PCR result and showed that no staff was newly identified as infected.
CONCLUSIONS: Thorough PCR testing, in combination with comprehensive and separate tests, is critical for managing COVID-19 outbreaks in nursing facilities, particularly, in units considered an epicenter. Serological testing is also beneficial for tracing contacts, confirming the number of infected individuals, and authorizing the termination of the outbreak.

Entities:  

Keywords:  Antibody testing; COVID-19 outbreak; Nursing facility; PCR testing; SARS-CoV-2

Mesh:

Year:  2021        PMID: 33722204      PMCID: PMC7957465          DOI: 10.1186/s12879-021-05972-5

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  9 in total

1.  Nursing Home Care in Crisis in the Wake of COVID-19.

Authors:  David C Grabowski; Vincent Mor
Journal:  JAMA       Date:  2020-07-07       Impact factor: 56.272

2.  COVID-19: protecting health-care workers.

Authors: 
Journal:  Lancet       Date:  2020-03-21       Impact factor: 79.321

Review 3.  COVID-19 testing and patients in mental health facilities.

Authors:  Nicole M Benson; Dost Öngür; John Hsu
Journal:  Lancet Psychiatry       Date:  2020-05-11       Impact factor: 27.083

Review 4.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure.

Authors:  Lauren M Kucirka; Stephen A Lauer; Oliver Laeyendecker; Denali Boon; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-05-13       Impact factor: 25.391

5.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

6.  SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes.

Authors:  N S N Graham; C Junghans; R Downes; C Sendall; H Lai; A McKirdy; P Elliott; R Howard; D Wingfield; M Priestman; M Ciechonska; L Cameron; M Storch; M A Crone; P S Freemont; P Randell; R McLaren; N Lang; S Ladhani; F Sanderson; D J Sharp
Journal:  J Infect       Date:  2020-06-03       Impact factor: 6.072

7.  Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients.

Authors:  Yong Chong; Hideyuki Ikematsu; Naoki Tani; Yoko Arimizu; Haruka Watanabe; Yukako Fukamachi; Akiko Yonekawa; Sho Iwasaka; Ruriko Nishida; Yoshihiro Eriguchi; Noriko Miyake; Shinji Shimoda; Yoji Nagasaki; Nobuyuki Shimono; Koichi Akashi
Journal:  Influenza Other Respir Viruses       Date:  2020-09-10       Impact factor: 4.380

8.  Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

Authors:  Temet M McMichael; Dustin W Currie; Shauna Clark; Sargis Pogosjans; Meagan Kay; Noah G Schwartz; James Lewis; Atar Baer; Vance Kawakami; Margaret D Lukoff; Jessica Ferro; Claire Brostrom-Smith; Thomas D Rea; Michael R Sayre; Francis X Riedo; Denny Russell; Brian Hiatt; Patricia Montgomery; Agam K Rao; Eric J Chow; Farrell Tobolowsky; Michael J Hughes; Ana C Bardossy; Lisa P Oakley; Jesica R Jacobs; Nimalie D Stone; Sujan C Reddy; John A Jernigan; Margaret A Honein; Thomas A Clark; Jeffrey S Duchin
Journal:  N Engl J Med       Date:  2020-03-27       Impact factor: 91.245

9.  Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.

Authors:  Elitza S Theel; Julie Harring; Heather Hilgart; Dane Granger
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

  9 in total
  3 in total

1.  Evaluation of SARS-CoV-2 antibody persistence and viral spread in stool: a long-term care experience before COVID-19 vaccination.

Authors:  Oya Ozlem Eren-Kutsoylu; Ozgur Appak; Arzu Nazli-Zeka; Gokcen Omeroglu-Simsek; Nil Tekin; Basak Bayram; Ayca Arzu Sayiner; Nesim Tanglay; Vildan Avkan-Oguz
Journal:  Ir J Med Sci       Date:  2022-07-12       Impact factor: 2.089

2.  Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.

Authors:  Yong Chong; Naoki Tani; Takeyuki Goto; Akiko Yonekawa; Hideyuki Ikematsu; Nobuyuki Shimono; Yosuke Tanaka; Koichi Akashi
Journal:  J Infect       Date:  2021-10-20       Impact factor: 6.072

3.  Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.

Authors:  Yong Chong; Takeyuki Goto; Naoki Tani; Akiko Yonekawa; Hideyuki Ikematsu; Nobuyuki Shimono; Yosuke Tanaka; Koichi Akashi
Journal:  Influenza Other Respir Viruses       Date:  2022-08-12       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.